ZyVersa Therapeutics, Inc.

8-K Other events Jul 16, 2026 8-K Director or officer change; Other events Jul 10, 2026 10-Q Quarter ended 2026-03-31 May 13, 2026 10-K Fiscal year ended 2025-12-31 Mar 31, 2026 8-K Entered a material agreement Mar 5, 2026 8-K Director or officer change Dec 3, 2025 8-K Results of operations (earnings release) Nov 19, 2025 10-Q Quarter ended 2025-09-30 Nov 19, 2025 8-K Director or officer change Oct 15, 2025 8-K Delisting notice or listing-rule failure Sep 18, 2025 10-Q Quarter ended 2025-06-30 Aug 13, 2025 8-K Other events Jul 28, 2025 8-K Delisting notice or listing-rule failure Jul 16, 2025 8-K Entered a material agreement; Unregistered sale of equity Jul 9, 2025 8-K Entered a material agreement; Unregistered sale of equity; Other events Jun 25, 2025 8-K Director or officer change; Shareholder vote results Jun 12, 2025 8-K Delisting notice or listing-rule failure May 30, 2025 10-Q Quarter ended 2025-03-31 May 12, 2025 8-K Changed accountants Apr 7, 2025 10-K Fiscal year ended 2024-12-31 Mar 27, 2025 8-K Entered a material agreement; Unregistered sale of equity; Shareholder vote results; Item 5.08; Other events Mar 7, 2025 8-K Results of operations (earnings release) Nov 14, 2024 10-Q Quarter ended 2024-09-30 Nov 14, 2024 8-K Entered a material agreement; Unregistered sale of equity Nov 6, 2024 8-K Director or officer change; Shareholder vote results Oct 30, 2024 8-K Entered a material agreement Sep 16, 2024 10-Q Quarter ended 2024-06-30 Aug 9, 2024 8-K Entered a material agreement; Unregistered sale of equity Aug 1, 2024 10-Q Quarter ended 2024-03-31 May 15, 2024 10-K/A Fiscal year ended 2023-12-31 May 15, 2024 8-K Modified rights of security holders; Amended charter or bylaws Apr 25, 2024 8-K Shareholder vote results; Regulation FD disclosure Apr 17, 2024 10-K Fiscal year ended 2023-12-31 Mar 25, 2024 8-K Delisting notice or listing-rule failure; Other events Mar 8, 2024 8-K Delisting notice or listing-rule failure Mar 1, 2024 8-K Changed accountants Dec 22, 2023 8-K Entered a material agreement; Regulation FD disclosure Dec 11, 2023 8-K Modified rights of security holders; Amended charter or bylaws; Regulation FD disclosure Nov 30, 2023 8-K Delisting notice or listing-rule failure Nov 17, 2023 10-Q Quarter ended 2023-09-30 Nov 14, 2023